{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:50:51Z","timestamp":1791100251184,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2679,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      <jats:bold>Hepatitis C virus (HCV) infects over 3% of the world population and is the leading cause of chronic liver disease worldwide. HCV has long been known to associate with circulating lipoproteins, and its interactions with the cholesterol and lipid pathways have been recently described. In this work, we demonstrate that HCV is actively secreted by infected cells through a Golgi-dependent mechanism while bound to very low density lipoprotein (vLDL). Silencing apolipoprotein B (ApoB) messenger RNA in infected cells causes a 70% reduction in the secretion of both ApoB-100 and HCV. More importantly, we demonstrate that the grapefruit flavonoid naringenin, previously shown to inhibit vLDL secretion both<\/jats:bold>\n                      <jats:bold>in vivo<\/jats:bold>\n                      <jats:bold>and<\/jats:bold>\n                      <jats:bold>in vitro<\/jats:bold>\n                      <jats:bold>, inhibits the microsomal triglyceride transfer protein activity as well as the transcription of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase and acyl-coenzyme A:cholesterol acyltransferase 2 in infected cells. Stimulation with naringenin reduces HCV secretion in infected cells by 80%. Moreover, we find that naringenin is effective at concentrations that are an order of magnitude below the toxic threshold in primary human hepatocytes and in mice.<\/jats:bold>\n                      <jats:bold>Conclusion:<\/jats:bold>\n                      <jats:bold>These results suggest a novel therapeutic approach for the treatment of HCV infection.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.22197","type":"journal-article","created":{"date-parts":[[2008,2,7]],"date-time":"2008-02-07T10:19:07Z","timestamp":1202379547000},"page":"1437-1445","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":248,"title":["Apolipoprotein B\u2013dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin"],"prefix":"10.1097","volume":"47","author":[{"given":"Yaakov","family":"Nahmias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"van Poll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L.","family":"Yarmush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20241201","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis.","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"R2-3-20241201","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00198849","article-title":"Association of hepatitis C virus in human sera with betalipoprotein.","volume":"181","author":"Thomssen","year":"1992","journal-title":"Med Microbiol Immunol"},{"key":"R3-3-20241201","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s004300000032","article-title":"Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus.","volume":"188","author":"Monazahian","year":"2000","journal-title":"Med Microbiol Immunol"},{"key":"R4-3-20241201","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510300429","article-title":"Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates.","volume":"30","author":"Sabile","year":"1999","journal-title":"HEPATOLOGY"},{"key":"R5-3-20241201","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.94.4.1200","article-title":"Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets.","volume":"94","author":"Barba","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-3-20241201","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1073\/pnas.0409834102","article-title":"Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids.","volume":"102","author":"Kapadia","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-3-20241201","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat Med"},{"key":"R8-3-20241201","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro.","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-3-20241201","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1128\/JVI.01150-06","article-title":"Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles.","volume":"80","author":"Gastaminza","year":"2006","journal-title":"J Virol"},{"key":"R10-3-20241201","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very lowdensity lipoproteins.","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-3-20241201","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","article-title":"Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viralrelated steatosis.","volume":"16","author":"Perlemuter","year":"2002","journal-title":"FASEB J"},{"key":"R12-3-20241201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-2275(20)40744-8","article-title":"Regulation of hepatic secretion of apolipoprotein Bcontaining lipoproteins: information obtained from cultured liver cells.","volume":"34","author":"Dixon","year":"1993","journal-title":"J Lipid Res"},{"key":"R13-3-20241201","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1016\/S0021-9258(18)67398-3","article-title":"Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes.","volume":"261","author":"Misumi","year":"1986","journal-title":"J Biol Chem"},{"key":"R14-3-20241201","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0271-5317(99)00144-X","article-title":"Hypocholesterolemic effects of dietary citrus juices in rabbits.","volume":"20","author":"Kurowska","year":"2000","journal-title":"Nutr Res"},{"key":"R15-3-20241201","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2337\/diabetes.54.6.1676","article-title":"Inhibition of microsomal triglyceride transfer protein expression and apolipoprotein B100 secretion by the citrus flavonoid naringenin and by insulin involves activation of the mitogenactivated protein kinase pathway in hepatocytes.","volume":"54","author":"Allister","year":"2005","journal-title":"Diabetes"},{"key":"R16-3-20241201","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0022-2275(20)31634-5","article-title":"Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.","volume":"42","author":"Wilcox","year":"2001","journal-title":"J Lipid Res"},{"key":"R17-3-20241201","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1194\/jlr.M200115-JLR200","article-title":"Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl esters.","volume":"43","author":"Borradaile","year":"2002","journal-title":"J Lipid Res"},{"key":"R18-3-20241201","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/bi026731o","article-title":"Hepatocyte ApoBcontaining lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTPmediated microsomal triglyceride accumulation.","volume":"42","author":"Borradaile","year":"2003","journal-title":"Biochemistry"},{"key":"R19-3-20241201","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2005-864785","article-title":"Hepatitis C virus particles and lipoprotein metabolism.","volume":"25","author":"Andre","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R20-3-20241201","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"R21-3-20241201","doi-asserted-by":"crossref","first-page":"39802","DOI":"10.1074\/jbc.M510391200","article-title":"Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion.","volume":"280","author":"Domitrovich","year":"2005","journal-title":"J Biol Chem"},{"issue":"pt 9","key":"R22-3-20241201","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1099\/vir.0.80071-0","article-title":"Expression of hepatitis C virus proteins in epithelial intestinal cells in vivo.","volume":"85","author":"Deforges","year":"2004","journal-title":"J Gen Virol"},{"key":"R23-3-20241201","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.21016","article-title":"Liver endothelial cells promote LDLR expression and the uptake of HCVlike particles in primary rat and human hepatocytes.","volume":"43","author":"Nahmias","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R24-3-20241201","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1073\/pnas.96.22.12766","article-title":"Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.","volume":"96","author":"Agnello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-3-20241201","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1096\/fj.05-4728fje","article-title":"The interaction of natural hepatitis C virus with human scavenger receptor SRBICla1 is mediated by ApoB containing lipoproteins.","volume":"20","author":"Maillard","year":"2006","journal-title":"FASEB J"},{"key":"R26-3-20241201","doi-asserted-by":"crossref","first-page":"10579","DOI":"10.1128\/JVI.00941-06","article-title":"Viral and cellular determinants of the hepatitis C virus envelopeheparan sulfate interaction.","volume":"80","author":"Barth","year":"2006","journal-title":"J Virol"},{"key":"R27-3-20241201","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1248\/bpb.28.527","article-title":"Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S180implanted mice.","volume":"28","author":"Kanno","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"R28-3-20241201","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tiv.2005.06.048","article-title":"Dietary flavonoids: effects on xenobiotic and carcinogen metabolism.","volume":"20","author":"Moon","year":"2006","journal-title":"Toxicol In Vitro"},{"key":"R29-3-20241201","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nut.2005.11.006","article-title":"Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.","volume":"22","author":"Huong","year":"2006","journal-title":"Nutrition"},{"key":"R30-3-20241201","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0261-5614(03)00059-1","article-title":"Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects.","volume":"22","author":"Jung","year":"2003","journal-title":"Clin Nutr"},{"key":"R31-3-20241201","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1006\/bbrc.2001.5001","article-title":"Antiatherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM1 and MCP1 in high cholesterolfed rabbits.","volume":"284","author":"Lee","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"R32-3-20241201","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/jmf.2006.9.582","article-title":"Naringin timedependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed highfat and highcholesterol diet.","volume":"9","author":"Kim","year":"2006","journal-title":"J Med Food"},{"key":"R34-3-20241201","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/90968","article-title":"Hepatitis C virus replication in mice with chimeric human livers.","volume":"7","author":"Mercer","year":"2001","journal-title":"Nat Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.22197","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200805000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T09:14:45Z","timestamp":1733044485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200805000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.22197","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1112195.568184","asserted-by":"object"}]},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}